Trial intelligence / Profile preview

Oral Ondansetron to Improve Patient Experience of Unsedated EGD

NCT07264738Phase 4Active, not recruiting

Sponsor
Peking Union Medical College Hospital
Start
Jul 2025
Primary completion
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ondansetron, sponsored by Peking Union Medical College Hospital. Started Jul 2025; status: active, not recruiting.

02

Drugs

ondansetron

Beyond the preview

Go deeper on NCT07264738.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07264738.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call